Back to TWO SIGMA INVESTMENTS, LP TWO SIGMA INVESTMENTS, LP

SABSSABS
4 quarters

Position history for TWO SIGMA INVESTMENTS, LPTWO SIGMA INVESTMENTS, LP's holdings in SAB BIOTHERAPEUTICS INC

TWO SIGMA INVESTMENTS, LP holds 214,632 shares of SABS (SAB BIOTHERAPEUTICS INC), worth $837,065 as of 2026-Q2. The position was increased (+18.5% shares). SABS represents 0.0% of TWO SIGMA INVESTMENTS, LP's portfolio.

Current Value

$837,065

Current Shares

214,632

Total Value Change

+$816,237

Total Shares Change

+189,538

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
214,632
+18.5%
$837,0650.0%$3.90
29
2026-Q1
New
181,185
-
$693,9390.0%$3.89
34
2023-Q3
Exited
0
-100.0%
$00.0%$6.30
0
2023-Q2
New
25,094
-
$20,8280.0%$7.73
26

Other major holders of SABS: ADAGE CAPITAL PARTNERS GP, L.L.C., RA CAPITAL MANAGEMENT, L.P., BALYASNY ASSET MANAGEMENT L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used